Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 9)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Metformin Added to Insulin Not Beneficial for T2D in Pregnancy
TUESDAY, Dec. 12, 2023 – For pregnant women with type 2 diabetes, the addition of metformin to insulin does not affect composite adverse neonatal outcomes, according to a study published in the Dec....
Half of Diabetes Patients on Ozempic, Mounjaro Stop Using the Meds
TUESDAY, Dec. 12, 2023 – Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new...
Diabetes Meds Like Ozempic, Mounjaro Might Also Lower Risks for Colon Cancer
FRIDAY, Dec. 8, 2023 – Could blockbuster diabetes and weight-loss meds such as Ozempic, Wegovy, Mounjaro and Zepbound also lower users' odds for colon cancer? New research suggests they might. All...
Earlier Age at Menarche Raises Type 2 Diabetes Risk
WEDNESDAY, Dec. 6, 2023 – Earlier age at menarche is associated with type 2 diabetes risk among women younger than 65 years, according to a study published online Dec. 5 in BMJ Nutrition Prevention ...
Starting Periods Early Linked to Higher Odds for Diabetes, Stroke
WEDNESDAY, Dec. 6, 2023 – Girls whose periods begin before the age of 13 are at higher risk of becoming adult women with diabetes, compared to girls who start menstruation later, new research shows....
Diabetes Tied to Identifiable Vocal Changes
FRIDAY, Dec. 1, 2023 – Vocal changes appear to occur in individuals with type 2 diabetes mellitus (T2DM) versus those without diabetes, according to a study published online in the December issue...
High Systolic BP Tied to Higher Cardiovascular Mortality in T2DM
FRIDAY, Dec. 1, 2023 – Clinic systolic blood pressure (BP) ≥130 mm Hg or diastolic BP levels ≥90 mm Hg are associated with a higher risk for cardiovascular disease (CVD) mortality in people with type...
Monthly News Roundup - November 2023
FDA Approves Lilly’s Zepbound for Chronic Weight Management In November, the U.S. Food and Drug Administration (FDA) approved Eli Lilly’s Zepbound (tirzepatide), a glucose-dependent insulinotropic pol...
Your Walking Speed Influences Your Risk for Diabetes
WEDNESDAY, Nov. 29, 2023 – People can walk away their risk of developing type 2 diabetes – but only if they walk fast enough, a new report finds. Folks who walk at least 2.5 miles an hour appear to h...
Walking at Faster Speeds Linked to Reduction in Risk for Type 2 Diabetes
WEDNESDAY, Nov. 29, 2023 – Walking at faster speeds seems to be associated with a reduction in the risk for type 2 diabetes, according to a review published online Nov. 28 in the British Journal of...
Mounjaro Beats Ozempic for Weight Loss in Early Trial
WEDNESDAY, Nov. 29, 2023 (Healthday News) – The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report. Both...
Study IDs Barriers to Eye Screening Among Adults With Diabetes
TUESDAY, Nov. 28, 2023 – Food insecurity, housing insecurity, mental health concerns, and the perceived importance of practitioner concordance are associated with a lower likelihood of receiving eye...
Insulin Manufacturers Employ Strategies to Extend Market Exclusivity
TUESDAY, Nov. 21, 2023 – Insulin manufacturers have employed strategies to extend periods of market exclusivity on brand-name insulin products, including filing patents after U.S. Food and Drug...
Short Sleep Duration Impairs Insulin Sensitivity in Women
FRIDAY, Nov. 17, 2023 – Short sleep duration for six weeks impairs insulin sensitivity in women, according to a study published online Nov. 15 in Diabetes Care. Faris M. Zuraikat, Ph.D., from the...
Type 2 Diabetes Linked to Increased Risk for Colorectal Cancer
WEDNESDAY, Nov. 15, 2023 – Type 2 diabetes is associated with an increased risk for colorectal cancer (CRC), with increased associations for those without colonoscopy screening and with smoking...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Lantus, Mounjaro, Trulicity, glipizide, semaglutide, Rybelsus, view more... Lantus Solostar, Humalog, Farxiga, Novolog, Jardiance, Janumet, insulin glargine, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, liraglutide, Invokana, Glucophage, Humulin N, insulin degludec